We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

137 hedge funds and large institutions have $314M invested in Spectrum Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $4.44M | Put options by funds: $3.32M

23% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 39

5% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 19

0% more funds holding

Funds holding: 137137 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less capital invested

Capital invested by funds: $329M → $314M (-$15.5M)

Holders
137
Holders Change
Holders Change %
0%
% of All Funds
3.65%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
20
Increased
48
Reduced
39
Closed
19
Calls
$4.44M
Puts
$3.32M
Net Calls
+$1.12M
Net Calls Change
+$2.4M
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$33.7M +$1.35M +202,807 +4%
State Street
2
State Street
Massachusetts
$28.4M +$8.59M +1,291,265 +38%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$25.8M
Vanguard Group
4
Vanguard Group
Pennsylvania
$24.9M -$233K -35,037 -0.8%
AC
5
Armistice Capital
New York
$16.4M +$4.31M +648,000 +32%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$14.1M +$9.49M +1,426,340 +158%
BIT
7
BlackRock Institutional Trust
California
$12.8M +$232K +34,875 +2%
Millennium Management
8
Millennium Management
New York
$11.4M -$18.5M -2,782,520 -60%
Goldman Sachs
9
Goldman Sachs
New York
$9.48M +$1.88M +282,930 +22%
Renaissance Technologies
10
Renaissance Technologies
New York
$8.45M +$7.61M +1,143,217 +461%
ACM
11
Ashford Capital Management
Delaware
$7.66M +$686K +103,092 +9%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$7.6M -$12.1K -1,817 -0.1%
RCAMU
13
Rothschild & Co Asset Management US
Connecticut
$7.07M +$686K +103,069 +10%
Citadel Advisors
14
Citadel Advisors
Florida
$6.49M +$6.5M +976,883 +1,051%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$6.17M -$100K -15,034 -1%
Barclays
16
Barclays
United Kingdom
$6.07M -$17K -2,558 -0.3%
Charles Schwab
17
Charles Schwab
California
$5.36M +$581K +87,296 +11%
BC
18
Broadfin Capital
New York
$4.86M +$5.32M +800,000 New
Northern Trust
19
Northern Trust
Illinois
$4.36M -$52.8K -7,929 -1%
Macquarie Group
20
Macquarie Group
Australia
$4.24M +$1.43M +215,678 +45%
PAM
21
Panagora Asset Management
Massachusetts
$4.06M +$2.07M +311,519 +87%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$3.64M +$94.3K +14,180 +2%
TA
23
Teachers Advisors
New York
$3.54M +$139K +20,900 +4%
Wells Fargo
24
Wells Fargo
California
$3.17M +$360K +54,045 +12%
Deutsche Bank
25
Deutsche Bank
Germany
$3.04M +$1.47M +220,317 +78%

SPPI Hedge Fund Activity: Q1 2015 in Review

137 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2015, worth a combined $314M — down 4.7% from $329M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SPPI positions and 19 closed out — a net gain of 1 holder — while 48 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $9.49M. The largest seller was Millennium Management, cutting an estimated $18.5M.

  • 137 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $314M of Spectrum Pharmaceuticals Inc stock for Q1 2015, down 4.7% quarter-over-quarter.
  • 20 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2015 and 19 closed out, a net change of +1 holder.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2015 was Wellington Management Group, an estimated $9.49M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2015 was Millennium Management, an estimated $18.5M sold.

Based on aggregated 13F filings for Q1 2015.